About our


Sandra Redmond

  • Murphy A, Redmond S. To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland. Value in Health. 2019;22(4):385-90.
  • Murphy A, Redmond S. Rapid Reviews with Health-Technology Assessments in Reimbursement Systems – an Examination of Ireland as a Case Study. 2017;4(1):grhta.5000250.
  • Wong B, Redmond S., O’Neill J. Iron deficiency in Patients with Heart Failure; Prevalence and Budget Impact. Forthcoming.
  • Nolan JJ, O’Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J. 2006 Nov-Dec;99(10):307-10.

Dr. Raymond Henderson

  • Henderson RH, French D, Maughan T, Adams R, Allemani C, Minicozzi P, Coleman MP, McFerran E, Sullivan R, Lawler M. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. The Lancet Gastroenterology & Hepatology. 2021 Jul 28.
  • Henderson R., Keeling P, French D, Smart D, Sullivan R, Lawler M. Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: a systematic review. Molecular Oncology. 2021 Jun 10.
  • Henderson, R., French, D., Sullivan, R., Maughan, T., Clarke, M., & Lawler, M. (2019). Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses. Oncotarget 10:3408-3423.
  • Henderson, R., O’Kane, M., McGilligan, V. and Watterson, S., 2016. The genetics and screening of familial hypercholesterolemia. Journal of Biomedical Science, 23(1), 39-51.
  • Henderson, R., Smart, D., French, D., Clark, J., Bloom, K. J., Hosty, D., and Lawler, M. (2020). Economic burden of not testing for FLT3 to treat acute myeloid leukemia. American Society for Clinical Oncology, Chicago (Abstract).